ZEINCRO is a leading contract research organization (CRO) that provides its services to more than 21 countries with special focus in the region of Central-and South-Eastern Europe.
|Industry||Interventional Studies - Phase I-IV, Non Interventional - Post Authorization Safety & Efficacy Studies, Regulatory Affairs, and Pharmacovigilance|
|Number of employees||51-200 employees|
With almost 20 years of experience in successful clinical research projects, more than 220 employees of ZEINCRO workforce have developed a thorough understanding of the communities and the regions in which it operates. We have established strong professional relations with local healthcare stakeholders. This approach allows ZEINCRO to set new standards for the successful clinical trials by delivering bespoke services that are flexibe, ethical and maximize patient recruitment and compliance. ZEINCRO combines the advantages of a CRO with local presence and local expertise. Its business is based on reliable partnerships and thus contributes to its long-term repeated business.
ZEINCRO provides clinical trial services to the global drug development industry and offers additional services in the areas of post-marketing safety and efficacy of studies, regulatory affairs and pharmacovigilance (IRISG), phase studies , including risk management plans. With more than 250 clients world wide, resulting in more than 40 long-term, ongoing collaborations. Among our customers are multinational and local pharmaceuticals cmpanies, global CROs, biotechnology and medical device companies as well as medical associations.
- -Act fast
- -Knowledge of local requirements and local culture
- -Reasonable budget
- -One point of contract
- Interventional Trials - Phase I - IV
- Non Interventional Trials - Post Authorization Safety and Efficacy Studies
- Regulatory Affairs
The business of pharmacovigilance/drug safety and product safety in general (medical device vigilance, veterinary pharmacovigilance, cosmetovigilance) is a business more based on trust between client and vendor than any other business. This is why quality is the main focus of their pharmacovigilance and product safety services since 2003. They are proud of our client centric company culture highly sensitive to individual needs. They know that no two clients are alike and our philosophy is to shape our support in the form of the best symbiosis with your needs and structure. Out of their European global hubs they are offering cost-effective solutions for global pre- and post-approval pharmacovigilance as well as related services in product safety (device vigilance, vetvigilance, cosmetovigilance). In addition they have deep roots on local level in multiple countries which enables them to serve your local needs with no subcontracting.
During the eleven years of their product safety operations they have grown vigilance teams with targeted expertise to achieve stability and have combined it with lean management, short timelines of implementation of projects, and efficient pathways of communication. Based on experience they have implemented a specialized recruitment approach to attract the right talent for the right pharmacovigilance tasks globally and regionally. Language proficiency is tested extensively before recruitment. Their strength is in their people who posses strong academic background (pharmacists, medical doctors and life-science graduates), deep knowledge of legislation, coming mostly from large CROs with years of hands-on experience in pre- and post-approval projects for large and middle-size pharma as well as device manufacturers. Zeincro Safety Officers posses long experience in AERS, ARISg and ARGUS. Year after year high retention rates secure continuity and are a basis for expansion.